Pro Health Tips
Thursday 26 November 2020
FDA Authorizes Monoclonal Antibodies for COVID-19 Treatment
US FDA issued an emergency use authorization for casirivimab and imdevimab for treatment of mild to moderate COVID-19.
from Medindia Health News https://ift.tt/3fBIRZQ
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
US FDA issued an emergency use authorization for casirivimab and imdevimab for treatment of mild to moderate COVID-19.
No comments:
Post a Comment